These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 6422007

  • 1. Four-drug combination chemotherapy (methotrexate, cyclophosphamide, hexamethylmelamine, and CCNU) for non-small cell bronchogenic carcinoma: a Cancer and Leukemia Group B study.
    Green M, Horton C, Spaulding M, Silver RT, Berenberg J, Kennedy BJ, Pajak TF, Comis R.
    J Clin Oncol; 1983 Sep; 1(9):559-65. PubMed ID: 6422007
    [Abstract] [Full Text] [Related]

  • 2. Lessons from a time capsule: evolution, not revolution, in therapy for advanced non-small-cell lung cancer.
    Green MR.
    J Clin Oncol; 2008 Jul 01; 26(19):3112-3. PubMed ID: 18591551
    [No Abstract] [Full Text] [Related]

  • 3. Combination chemotherapy with CCNU (NSC-79037),hexamethylmelamine (NSC-13875) and methotrexate (NSC-740) in advanced bronchogenic carcinoma.
    DiBella NJ, Nelson RA, Norgard MJ.
    Oncology; 1975 Jul 01; 32(2):82-5. PubMed ID: 815858
    [Abstract] [Full Text] [Related]

  • 4. A randomized clinical trial in bronchogenic small-cell carcinoma evaluating alternating maintenance therapy of vincristine, adriamycin, procarbazine, and etoposide (VAPE) with cyclophosphamide, CCNU, and methotrexate (CCM) versus CCM maintenance alone in complete responders following VAPE induction and late intensification.
    Broder LE, Sridhar KS, Selawry OS, Charyulu KN, Rao RK, Saldana MJ, Donnelly EJ, Raub WA.
    Am J Clin Oncol; 1994 Dec 01; 17(6):527-37. PubMed ID: 7977175
    [Abstract] [Full Text] [Related]

  • 5. Effects of amphotericin B with combination chemotherapy on response rates and on survival in non-small cell carcinoma of the lung.
    Presant CA, Metter GE, Multhauf P, Bertrand M, Chang FF, Klein L, Rappaport D, Kendregan B, Mackie A.
    Cancer Treat Rep; 1984 Apr 01; 68(4):651-4. PubMed ID: 6201270
    [Abstract] [Full Text] [Related]

  • 6. Methotrexate in the chemotherapy of lung cancer.
    Smyth JF, Ford HT.
    Cancer Treat Rep; 1981 Apr 01; 65 Suppl 1():161-3. PubMed ID: 6275986
    [Abstract] [Full Text] [Related]

  • 7. A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B.
    Chahinian AP, Propert KJ, Ware JH, Zimmer B, Perry MC, Hirsh V, Skarin A, Kopel S, Holland JF, Comis RL.
    J Clin Oncol; 1989 Aug 01; 7(8):993-1002. PubMed ID: 2547030
    [Abstract] [Full Text] [Related]

  • 8. Combination chemotherapy in metastatic or recurrent non-small cell bronchogenic carcinoma. 5-year results.
    Ojala A, Nikkanen VN, Paloheimo S, Palojoki A, Thölix E.
    Strahlentherapie; 1983 Dec 01; 159(12):775-7. PubMed ID: 6364459
    [Abstract] [Full Text] [Related]

  • 9. Six-drug chemotherapy (hexamethylmelamine, doxorubicin, cisplatin, cyclophosphamide, methotrexate, and 5-FU; CHAMP-5) for ovarian carcinoma: alternating sequences of combination regimens.
    Pasmantier MW, Coleman M, Silver RT, Ballard WP.
    Cancer Treat Rep; 1985 Jun 01; 69(6):689-93. PubMed ID: 3926310
    [Abstract] [Full Text] [Related]

  • 10. Chemotherapy for metastatic non-small cell bronchogenic carcinoma: EST 2575, generation III, HAM versus CAMP.
    Ruckdeschel JC, Mehta CR, Salazar OM, Creech RH, Sponzo RW.
    Cancer Treat Rep; 1981 Jun 01; 65(11-12):959-63. PubMed ID: 6794909
    [Abstract] [Full Text] [Related]

  • 11. Six-drug combination chemotherapy for nonresectable bronchogenic carcinoma.
    Miller CF, Weltz MD, Heim WJ, Blom J.
    Cancer Treat Rep; 1979 Aug 01; 63(8):1351-3. PubMed ID: 113094
    [No Abstract] [Full Text] [Related]

  • 12. Intensive chemotherapy of small cell bronchogenic carcinoma.
    Cohen MH, Creaven PJ, Fossieck BE, Broder LE, Selawry OS, Johnston AV, Williams CL, Minna JD.
    Cancer Treat Rep; 1977 Aug 01; 61(3):349-54. PubMed ID: 194691
    [Abstract] [Full Text] [Related]

  • 13. Mitomycin-C, etoposide, cisplatin, and hexamethylmelamine (MEPH) as a second-line regimen in lung cancer.
    Chahinian AP, Green G, Holland JF.
    Am J Clin Oncol; 1984 Oct 01; 7(5):419-23. PubMed ID: 6439029
    [Abstract] [Full Text] [Related]

  • 14. Chemotherapy for bronchogenic carcinoma. Methotrexate, doxorubicin, cyclophosphamide, and lomustine.
    Chahinian PA, Arnold DJ, Cohen JM, Purpora DP, Jaffrey IS, Teirstein AS, Kirschner PA, Holland JF.
    JAMA; 1977 May 30; 237(22):2392-6. PubMed ID: 576939
    [Abstract] [Full Text] [Related]

  • 15. A phase II clinical trial evaluating the use of two sequential, four-drug combination chemotherapy regimens in ambulatory bronchogenic adenocarcinoma patients.
    Broder LE, Sridhar KS, Selawry OS, Charyulu KN, Rao RK, Saldana MJ, Lenz C.
    Am J Clin Oncol; 1992 Dec 30; 15(6):480-6. PubMed ID: 1449109
    [Abstract] [Full Text] [Related]

  • 16. Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine.
    Mintz U, Bitran JD, Cooksey JA, Desser RK, DeMeester TR, Golomb HM.
    Cancer Treat Rep; 1978 Apr 30; 62(4):567-9. PubMed ID: 77725
    [No Abstract] [Full Text] [Related]

  • 17. Metastatic non-small cell bronchogenic carcinoma: a randomized trial of sequential vs combination chemotherapy.
    Hoffman PC, Newman SB, Golomb HM, Demeester TR, Blough RR, Sovik CA.
    Eur J Cancer Clin Oncol; 1983 Jan 30; 19(1):33-8. PubMed ID: 6303793
    [Abstract] [Full Text] [Related]

  • 18. Phase II trial of mitomycin, vindesine, and hexamethylmelamine in metastatic non-small cell bronchogenic carcinoma.
    Bonomi PD, Pazdur R, Stolbach L, Mason B, Ettinger D.
    Cancer Treat Rep; 1986 Dec 30; 70(12):1447-8. PubMed ID: 3024827
    [Abstract] [Full Text] [Related]

  • 19. Combined modality therapy with radiotherapy, chemotherapy, and immunotherapy in limited small-cell carcinoma of the lung: a Phase III cancer and Leukemia Group B Study.
    Maurer LH, Pajak T, Eaton W, Comis R, Chahinian P, Faulkner C, Silberfarb PM, Henderson E, Rege VB, Baldwin PE.
    J Clin Oncol; 1985 Jul 30; 3(7):969-76. PubMed ID: 2991478
    [Abstract] [Full Text] [Related]

  • 20. Methyl-CCNU, alone and in combination with vincristine, or vincristine and methotrexate, in advanced bronchogenic carcinoma.
    Richards F, Cooper MR, Muss HB, White DR, Spurr CL.
    Cancer; 1976 Sep 30; 38(3):1077-82. PubMed ID: 953956
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.